Pharmacist Cardiovascular | Chronic Kidney Disease | Diabetes Podcast 45 credit minutes

Cardiovascular-Kidney-Metabolic (CKM) syndrome recognizes the interconnected relationship among cardiovascular disease, kidney disease, obesity, diabetes, and other metabolic risk factors that contribute to long-term health outcomes. The first-ever CKM clinical practice guideline introduces a framework for risk assessment, staging, prevention, and management, emphasizing early identification and coordinated care across disease states. You will be better prepared to recognize CKM syndrome, understand its implications for patient care, and support evidence-based strategies to reduce cardiovascular, kidney, and metabolic risk. 

Learning Objectives

1. Describe the stages and key components of cardiovascular-kidney-metabolic syndrome.

2. Explain evidence-based strategies for identifying and managing patients at risk for CKM syndrome.

Faculty

Rachel Maynard, PharmD

Disclosures:

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BCADM, CDCES, FCCP

Disclosures:

Christine Schumacher is a Speaker and Advisory Board Member for Abbott. All relevant financial relationships have been mitigated.

Course Details